 Strides Pharma Science Ltd consolidated Q2FY26 net profit climbs to Rs. 127.53 crores
Strides Pharma Science Ltd consolidated Q2FY26 net profit climbs to Rs. 127.53 crores ASI Industries Ltd Q2FY26 profit at Rs. 81.30 lakhs
ASI Industries Ltd Q2FY26 profit at Rs. 81.30 lakhs Jubilant Pharmova Ltd consolidated Q2FY26 net profit rises to Rs. 120.3 crores
Jubilant Pharmova Ltd consolidated Q2FY26 net profit rises to Rs. 120.3 crores Bharat Electronics Ltd Q2 FY2025-26 consolidated profit at Rs. 1287.77 crores
Bharat Electronics Ltd Q2 FY2025-26 consolidated profit at Rs. 1287.77 crores ACC Ltd consolidated Q2 FY2026 PAT zooms to Rs. 1119.23 crores
ACC Ltd consolidated Q2 FY2026 PAT zooms to Rs. 1119.23 crores 
              The Nomination and Remuneration / Compensation committee of Aurobindo Pharma Ltd on March 30, 2017 has allotted 15000 equity shares of Re.1/- each under ESOP of the Company.
Consequent to the allotment, the paid up share capital of the company has increased from 58,58,67,409 equity shares of Rs. 1 each to 58,58,82,409 equity shares of Rs. 1 each.
Shares of AUROBINDO PHARMA LTD. was last trading in BSE at Rs.674.35 as compared to the previous close of Rs. 671.45. The total number of shares traded during the day was 160255 in over 3136 trades.
The stock hit an intraday high of Rs. 681.5 and intraday low of 668.5. The net turnover during the day was Rs. 108416602.